PubRank

Robin M Rudd

Author PubWeight™ 12.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Defective core-apoptosis signalling in diffuse malignant pleural mesothelioma: opportunities for effective drug development. Lancet Oncol 2004 1.70
2 Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest 2003 1.64
3 In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion. Clin Cancer Res 2006 1.42
4 Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. J Clin Oncol 2006 1.39
5 The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest 2003 1.30
6 The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma. Lung Cancer 2008 1.06
7 Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma. Lung Cancer 2005 0.89
8 Prognostic factors in mesothelioma. Lung Cancer 2005 0.87
9 Asbestos-induced and smoking-related disease: apportioning pulmonary function deficit by using thin-section CT. Radiology 2006 0.85
10 Efficacy and safety of first- or second-line irinotecan, cisplatin, and mitomycin in mesothelioma. Cancer 2007 0.78
11 Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer. Int J Cancer 2007 0.76
12 Chemotherapy and radiotherapy of bronchial carcinoma. Hosp Med 2003 0.75
13 Pulmonary toxicity and cancer treatment. Hosp Med 2004 0.75
14 Diffuse pleural mesothelioma with epithelioid and angiosarcomatous components--a hitherto undescribed pattern of differentiation. Histopathology 2012 0.75